Pump, pipes, filter, sugar, weight, and more: the pluripotent prowess of semaglutide

Graphical AbstractGLP-1RA therapy and cardiorenal protection in diabetes. (A) The semaglutide efficacy nonet. (B) The formidable four pillars of cardiorenal protection in diabetes. GLP-1RA, glucagon-like peptide-1 receptor agonist; HbA1C, glycated haemoglobin; HFmrEF, heart failure with mildly reduced ejection fraction; HFpEF, heart failure with preserved ejection fraction; MACE, major adverse cardiovascular events; T2D, type 2 diabetes.Open in new tabDownload slide